ImmuniWeb® Neuron Mobile
Dynamic application security testing (DAST) software
Static application security testing (SAST) software
Vulnerability scanner software
DevSecOps software
- Features
- Ease of use
- Ease of management
- Quality of support
- Affordability
- Market presence
Take the quiz to check if ImmuniWeb® Neuron Mobile and its alternatives fit your requirements.
Pay-as-you-go
Free Trial
Free version unavailable
Small
Medium
Large
- Real estate and property management
- Professional services (engineering, legal, consulting, etc.)
- Healthcare and life sciences
What is ImmuniWeb® Neuron Mobile
ImmuniWeb® Neuron Mobile is a mobile application security testing product focused on identifying vulnerabilities and security weaknesses in iOS and Android apps. It supports security teams and development organizations that need repeatable testing for mobile releases and ongoing risk monitoring. The product combines automated scanning with reporting and remediation guidance oriented to mobile-specific issues (for example, insecure data storage, weak transport security, and risky third-party components). It is positioned as part of ImmuniWeb’s broader application security testing portfolio and can be used alongside DevSecOps processes.
Mobile-focused security coverage
The product is purpose-built for iOS and Android application testing rather than general web-only scanning. This focus typically aligns better with mobile threat models such as client-side data exposure, certificate/transport configuration issues, and mobile app hardening gaps. It fits teams that need a dedicated workflow for mobile apps instead of adapting web scanners to mobile artifacts. It also supports use cases where mobile apps are a primary customer channel and require frequent security checks.
Automated scanning and reporting
Neuron Mobile emphasizes automated identification of security issues and structured reporting for remediation. This can reduce reliance on purely manual testing for routine checks and help standardize findings across releases. Automated outputs are generally easier to operationalize in recurring security programs than ad-hoc assessments. The approach supports repeatability for regression testing after fixes.
Fits broader AppSec programs
The product is part of a wider ImmuniWeb platform, which can help organizations consolidate mobile testing within a broader application security strategy. This can be useful when security teams want consistent governance, reporting, and risk tracking across multiple application types. It also supports integration into development and security operations processes where mobile is one component of the overall portfolio. Consolidation can reduce tool sprawl for teams managing multiple testing modalities.
Depth varies by test type
Mobile security testing often requires a mix of static analysis, dynamic/runtime testing, and manual validation to confirm exploitability. Automated scanning alone may miss logic flaws, authorization issues, or complex abuse cases that require human-driven testing. Organizations with high assurance requirements may still need complementary manual assessments. Buyers should validate which findings are verified versus heuristic.
Integration details not uniform
DevSecOps adoption depends on the availability and maturity of CI/CD integrations, APIs, and workflow connectors. If the product’s integrations do not match an organization’s toolchain, teams may need custom automation to operationalize results. This can slow rollout compared with tools that provide prebuilt connectors for common pipelines and ticketing systems. Prospective users should confirm supported integrations and export formats.
Mobile artifact handling constraints
Mobile testing workflows can be constrained by how the tool ingests and analyzes artifacts (for example, IPA/APK requirements, signing, obfuscation, or build variants). Some environments also require on-prem or restricted-data processing due to regulatory or IP concerns. If deployment options or artifact requirements do not align with internal policies, adoption may be limited. Teams should confirm deployment model, data residency options, and supported build configurations.
Plan & Pricing
Pricing model: Pay-as-you-go / per-scan (usage-based) Free tier/trial: Free community online mobile test tool available (limited); Free trial of ImmuniWeb® Neuron Mobile explicitly offered on product page. Example costs:
- ImmuniWeb® Neuron Mobile — Price per scan: €99 per scan (instant online purchase available).
- Expert-Guided / Enterprise — Custom pricing; contact sales (volume & NGO discounts, customizable contracts, personal manager).
- ImmuniWeb Community / Mobile free-tool premium accounts (related community offering):
- Premium 10 — 10 tests/month — €49 per month
- Premium 20 — 20 tests/month — €99 per month
- Premium 30 — 30 tests/month — €199 per month
- Premium 40 — 40 tests/month — €299 per month
- Premium 50 — 50 tests/month — €399 per month
- Premium 100 — 100 tests/month — €499 per month Discount options: 3-month subscription: 5% off; 6-month: 10% off; 12-month: 15% off. Volume & NGO discounts are offered for expert-guided/enterprise deals.
Seller details
ImmuniWeb SA
Geneva, Switzerland
2019
Private
https://www.immuniweb.com/
https://x.com/immuniweb
https://www.linkedin.com/company/immuniweb/
